{
  "id": "cluster_34_docid1",
  "content": "A new implantable cardioverter-defibrillator (ICD) was placed for patient #99245-LK after recurrent ventricular tachycardia episodes. Dr. Elise Varga at Hartford Cardiac Institute noted the patient's history of arrhythmogenic right ventricular dysplasia (ARVD). Post-implant survey indicated stable recovery with follow-up scheduled in 6 weeks. Out-of-network authorization was approved under Policy 2307-ICD.",
  "metadata": {
    "format": "medical_record"
  }
}